Agios Pharmaceuticals AGIO Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agios Pharmaceuticals's total cost of revenue?
- Agios Pharmaceuticals (AGIO) reported total cost of revenue of $1.32M in Q1 2026.
- How has Agios Pharmaceuticals's total cost of revenue changed year-over-year?
- Agios Pharmaceuticals's total cost of revenue increased by 21.6% year-over-year, from $1.09M to $1.32M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.